Air Voel believes in sleep health, offering cutting-edge CPAP devices that are reliable and adjustable for restful sleep. Air Voel allows people to manage their health with innovative technology, ...

Q1 2025 Earnings Call Transcript October 24, 2024 ResMed Inc. beats earnings expectations. Reported EPS is $2.2, expectations ...

ResMed ( ASX: RMD) shares opened 8% higher as the market opened on Friday after the company reported a better-than-expected ...

ResMed's obligation is to help these sleep ... there is obviously some combination of the switch from AirSense 10 to AirSense 11 in the countries where that's improved and that has a higher ...

Hello, and welcome to the Q1 fiscal year 2025 ResMed Earnings conference call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) Please note this conference call is ...

ResMed Inc (RMD) reports robust revenue growth and increased profitability, while navigating freight cost pressures and ...

Device Sales Growth: Increased by 10% globally ... showcasing strong financial performance. ResMed Inc (NYSE:RMD) is expanding the availability of its AirSense 11 platform worldwide, which ...

ResMed is redoubling efforts to increase resupply with plans to make Snap, a software platform that monitors orders, ...

A stellar first quarter has underscored ResMed's share price bounce-back from last year's obesity drug panic, and perhaps put ...

Shares in narrow-moat ResMed RMD remain undervalued following a solid first-quarter fiscal 2025. Underlying earnings before ...

Lastly, Farrell believes the rise of GLPs will have a Botox effect on sleep apnea, as patients become more aware of the disease and doctors use all tools to treat the disease, including ResMed’s ...